Chromosome region 3q26, which contains SKIL gene, was found to be amplified in 31.2% of NSCLC18, and similarly, our results showed that SKIL expression was elevated in tumor samples of NSCLC patients (see Fig. 1). This evidence concerns the gene SKIL and neoplasm.